Stay updated with breaking news from Opgen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Precigen, Inc. (NASDAQ:PGEN – Get Rating) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.34 and traded as low as $1.14. Precigen shares last traded at $1.18, with a volume of 980,821 shares trading hands. Analyst Ratings Changes PGEN has been the […]
ROCKVILLE, Md., May 01, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power...
The Manufacturers Life Insurance Company boosted its holdings in shares of Precigen, Inc. (NASDAQ:PGEN – Get Rating) by 96.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 43,234 shares of the biotechnology company’s stock after purchasing an additional 21,269 shares […]
OpGen, Inc. (NASDAQ:OPGN – Get Rating) saw a significant drop in short interest in March. As of March 31st, there was short interest totalling 303,400 shares, a drop of 44.4% from the March 15th total of 545,300 shares. Based on an average daily volume of 456,500 shares, the short-interest ratio is currently 0.7 days. Currently, […]
StockNews.com upgraded shares of OpGen (NASDAQ:OPGN – Get Rating) to a sell rating in a report released on Friday morning. OpGen Stock Performance NASDAQ:OPGN opened at $1.33 on Friday. The firm has a market cap of $3.56 million, a PE ratio of -0.09 and a beta of -0.22. OpGen has a fifty-two week low of […]